The Philips cath lab experience provides interaction between image acquisition and visualization technologies, hemodynamic monitoring and charting, cath lab and statistical reporting and multimodality image access, viewing and storage.

CT Comprehensive Cardiac Analysis (CCA) with 3D-QCA from Philips is used to perform detailed evaluation of the coronary arteries and advanced ventricular functional analysis.

The CX50 CompactXtreme ultrasound system brings premium technologies from the Philips iE33 system to a compact form.

October 13, 2008 – Piedmont Hospital in Atlanta, GA, is installing the Aquilion ONE from Toshiba America Medical Systems in an effort to streamline the series of diagnostic tests that patients with heart conditions or stroke undergo.

With the Aquilion ONE, a dynamic volume CT system, physicians can reportedly provide one comprehensive exam, reduce cost by eliminating multiple tests and access complete information to diagnose and treat patients faster.

October 12, 2008 – Research results indicate that optical coherence tomography (OCT) may be the best tool available to detect vulnerable plaque (VP) in coronary arteries, according to findings that will be presented at the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF).

October 13, 2008 – GE Healthcare is featuring real-time imaging solutions made possible, in part, by new collaborative partnerships, at TCT 2008

The GE Innova cardiovascular X-ray system will soon be aided by the new Innova Dose, Innova 3D and Innova with Stent Technologies features. GE’s Innova Dose package aims to deliver superb image quality and custom dose management.

October 13, 2008 - Boston Scientific Corp. released comprehensive data for the TAXUS ATLAS clinical program, a series of global, prospective, multi-center, single-arm, historically controlled trials, which evaluate the TAXUS Liberte Paclitaxel-Eluting Stent System in a variety of lesions and patient groups.

The TAXUS Liberte Stent received FDA approval last week. Results from the TAXUS ATLAS Workhorse, Direct Stenting, Small Vessel and Long Lesion trials were presented at TCT 2008.

October 13, 2008 – At TCT 2008, Boston Scientific Corp. announced results from an analysis of nearly 7,500 patients from its TAXUS ARRIVE 1 and 2 registries, which are designed to confirm the performance of the TAXUS Express2 Paclitaxel-Eluting Coronary Stent System in real-world practice.

October 13, 2008 - Of those treated with Medtronic’s Endeavor Resolute drug-eluting stent (DES) in the RESOLUTE IDE trial, only two patients required repeat procedures – a 1.5 percent rate of target lesion revascularization (TLR) – at two years following implant, according to data released today at TCT 2008.

There were no instances of stent thrombosis among the 130 study subjects – all of whom received an Endeavor Resolute DES – through 24 months of follow-up.

October 13, 2008 - GE Healthcare and Boston Scientific Corp. agreed to collaborate to improve intravascular ultrasound (IVUS) workflow between the GE Healthcare Innova Cardiovascular X-ray System and the Boston Scientific iLab Ultrasound Imaging System.

Boston Scientific and GE will offer advances in the field of IVUS to joint customers, and are displaying the iLab and Innova Systems at the Oct. 12-17 Transcatheter Cardiovascular Therapeutics (TCT) Scientific Symposium in Washington, D.C.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now